MentionFox
Home › Stakes › DNA X, Inc.
5%+ stakes · Schedule 13D and 13G

DNA X, Inc.: 5%+ holders

Who has reported owning 5% or more of DNA X, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more2
Filings16
Latest filing2026-08-13

DNA X, Inc. has 16 Schedule 13D or 13G filings on record since 2025-07-02. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
DNA Holdings Venture Inc.19.9%223,201SCHEDULE 13D, 2026-02-202025-12-15
Lytton Laurence W6.8%100,521SCHEDULE 13G/A, 2026-08-132026-06-30
CVI Investments, Inc.0%0SCHEDULE 13G/A, 2025-11-072025-09-30
L1 Capital Global Opportunities Master Fund, Ltd.0%0SCHEDULE 13G/A, 2025-11-142025-11-14
1 Main Capital Management, LLC0%0SCHEDULE 13G/A, 2026-02-172025-12-31
Streeterville Capital LLC0%0SCHEDULE 13G/A, 2026-01-23

Purpose of Transaction (Item 4)

DNA Holdings Venture Inc.

The information set forth in or incorporated by reference in Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. Under the Membership Interest Purchase Agreement, DNA Holdings also agreed to vote all shares of the Issuer's common stock beneficially owned by DNA Holdings in favor of the asset purchase agreement, dated July 17, 2025, as subsequently amended and as amended from time to time, by and among the Issuer, Pace Car Acquisition LLC, the seller representative named in the asset purchase agreement, and Social Mobile Technology Holdings LLC (the "Asset Purchase Agreement") and granted the officers and directors of the Issuer irrevocable proxy to vote for the adoption of the Asset Purchase Agreement and against any proposal made in opposition to, or in competition with, the consummation of the Asset Purchase Agreement until the earlier of January 15, 2026 and the termination of the Asset Purchase Agreement. Pursuant to the Membership Interest Purchase Agreement, so long as DNA Holdings, directly or indirectly, beneficially owns at least 5% of the Issuer's outstanding common stock, DNA Holdings will have the right under the Membership Interest Purchase Agreement to designate one officer and one nominee for election to the Issuer's board of directors, and the Issuer will be required to take reasonably necessary corporate action to appoint such designees, subject to the oversight of the Issuer's nominating and governance …The first part of Item 4 of the SCHEDULE 13D filed 2026-02-20; the filing has the rest

Timeline

FiledHolderPercentFiling
2025-07-02Lytton Laurence W11.2%SCHEDULE 13G/A
2025-07-03CVI Investments, Inc.7.3%SCHEDULE 13G
2025-07-07L1 Capital Global Opportunities Master Fund, Ltd.7.28%SCHEDULE 13G
2025-07-09Lytton Laurence W5.6%SCHEDULE 13G/A
2025-09-041 Main Capital Management, LLC5.1%SCHEDULE 13G
2025-11-07CVI Investments, Inc.0%SCHEDULE 13G/A
2025-11-14Lytton Laurence W7.8%SCHEDULE 13G/A
2025-11-14L1 Capital Global Opportunities Master Fund, Ltd.0%SCHEDULE 13G/A
2025-11-141 Main Capital Management, LLC8.2%SCHEDULE 13G/A
2025-12-18Streeterville Capital LLC9.9%SCHEDULE 13G
2026-01-23Streeterville Capital LLC0%SCHEDULE 13G/A
2026-02-17Lytton Laurence W9.96%SCHEDULE 13G/A
2026-02-171 Main Capital Management, LLC0%SCHEDULE 13G/A
2026-02-20DNA Holdings Venture Inc.19.9%SCHEDULE 13D
2026-05-15Lytton Laurence W8.1%SCHEDULE 13G/A
2026-08-13Lytton Laurence W6.8%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for DNA X, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/dna-x
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
DNA X, Inc. 5%+ holders: 2 at 5% or more, largest DNA Holdings Venture Inc. 19.9%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/dna-x